These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 30504137)

  • 1. Extrapolation of In Vivo Hepatic Clearance from In Vitro Uptake Clearance by Suspended Human Hepatocytes for Anionic Drugs with High Binding to Human Albumin: Improvement of In Vitro-to-In Vivo Extrapolation by Considering the "Albumin-Mediated" Hepatic Uptake Mechanism on the Basis of the "Facilitated-Dissociation Model".
    Kim SJ; Lee KR; Miyauchi S; Sugiyama Y
    Drug Metab Dispos; 2019 Feb; 47(2):94-103. PubMed ID: 30504137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Phenomenon of Albumin-Mediated Hepatic Uptake of Organic Anion Transport Polypeptide Substrates: Prediction of the In Vivo Uptake Clearance from the In Vitro Uptake by Isolated Hepatocytes Using a Facilitated-Dissociation Model.
    Miyauchi S; Masuda M; Kim SJ; Tanaka Y; Lee KR; Iwakado S; Nemoto M; Sasaki S; Shimono K; Tanaka Y; Sugiyama Y
    Drug Metab Dispos; 2018 Mar; 46(3):259-267. PubMed ID: 29298773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extrapolation of the Hepatic Clearance of Drugs in the Absence of Albumin In Vitro to That in the Presence of Albumin In Vivo: Comparative Assessement of 2 Extrapolation Models Based on the Albumin-Mediated Hepatic Uptake Theory and Limitations and Mechanistic Insights.
    Poulin P; Haddad S
    J Pharm Sci; 2018 Jul; 107(7):1791-1797. PubMed ID: 29567347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consideration of albumin-mediated hepatic uptake for highly protein-bound anionic drugs: Bridging the gap of hepatic uptake clearance between in vitro and in vivo.
    Miyauchi S; Kim SJ; Lee W; Sugiyama Y
    Pharmacol Ther; 2022 Jan; 229():107938. PubMed ID: 34171335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Albumin-Mediated Uptake Improves Human Clearance Prediction for Hepatic Uptake Transporter Substrates Aiding a Mechanistic In Vitro-In Vivo Extrapolation (IVIVE) Strategy in Discovery Research.
    Li N; Badrinarayanan A; Ishida K; Li X; Roberts J; Wang S; Hayashi M; Gupta A
    AAPS J; 2020 Nov; 23(1):1. PubMed ID: 33196949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of In Vitro to In Vivo Extrapolation Approaches for Predicting Transporter-Mediated Hepatic Uptake Clearance Using Suspended Rat Hepatocytes.
    Li N; Badrinarayanan A; Li X; Roberts J; Hayashi M; Virk M; Gupta A
    Drug Metab Dispos; 2020 Oct; 48(10):861-872. PubMed ID: 32759366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Human Plasma on Hepatic Uptake of Organic Anion-Transporting Polypeptide 1B Substrates: Studies Using Transfected Cells and Primary Human Hepatocytes.
    Bi YA; Ryu S; Tess DA; Rodrigues AD; Varma MVS
    Drug Metab Dispos; 2021 Jan; 49(1):72-83. PubMed ID: 33139461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic Organic Anion Transporting Polypeptide-Mediated Clearance in the Beagle Dog: Assessing In Vitro-In Vivo Relationships and Applying Cross-Species Empirical Scaling Factors to Improve Prediction of Human Clearance.
    Matsunaga N; Ufuk A; Morse BL; Bedwell DW; Bao J; Mohutsky MA; Hillgren KM; Hall SD; Houston JB; Galetin A
    Drug Metab Dispos; 2019 Mar; 47(3):215-226. PubMed ID: 30593544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using the Dynamic Well-Stirred Model to Extrapolate Hepatic Clearance of Organic Anion-Transporting Polypeptide Transporter Substrates without Assuming Albumin-Mediated Hepatic Drug Uptake.
    Yan Z; Ma L; Hwang N; Huang J; Kenny JR; Hop CECA
    Drug Metab Dispos; 2024 May; 52(6):548-554. PubMed ID: 38604729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Albumin-Mediated Drug Uptake by Organic Anion Transporter 1/3 Is Real: Implications for the Prediction of Active Renal Secretion Clearance.
    Tan SPF; Tillmann A; Murby SJ; Rostami-Hodjegan A; Scotcher D; Galetin A
    Mol Pharm; 2024 Sep; 21(9):4603-4617. PubMed ID: 39166754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting Human Clearance of Organic Anion Transporting Polypeptide Substrates Using Cynomolgus Monkey: In Vitro-In Vivo Scaling of Hepatic Uptake Clearance.
    De Bruyn T; Ufuk A; Cantrill C; Kosa RE; Bi YA; Niosi M; Modi S; Rodrigues AD; Tremaine LM; Varma MVS; Galetin A; Houston JB
    Drug Metab Dispos; 2018 Jul; 46(7):989-1000. PubMed ID: 29720472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-in-Human Predictions of Hepatic Clearance for Drugs With the Well-Stirred Model: Comparative Assessment Between Models of Fraction Unbound Based Either on the Free Drug Hypothesis, Albumin-Facilitated Hepatic Uptake or Dynamic Binding Kinetics.
    Poulin P
    J Pharm Sci; 2024 Aug; 113(8):2641-2650. PubMed ID: 38796154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vitro Hepatic Uptake in Human and Monkey Hepatocytes in the Presence and Absence of Serum Protein and Its In Vitro to In Vivo Extrapolation.
    Liang X; Park Y; DeForest N; Hao J; Zhao X; Niu C; Wang K; Smith B; Lai Y
    Drug Metab Dispos; 2020 Dec; 48(12):1283-1292. PubMed ID: 33037043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Nonlinear Pharmacokinetics of a Highly Albumin-Bound Compound: Contribution of Albumin-Mediated Hepatic Uptake Mechanism.
    Fukuchi Y; Toshimoto K; Mori T; Kakimoto K; Tobe Y; Sawada T; Asaumi R; Iwata T; Hashimoto Y; Nunoya KI; Imawaka H; Miyauchi S; Sugiyam Y
    J Pharm Sci; 2017 Sep; 106(9):2704-2714. PubMed ID: 28465151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the Predictability of Human Hepatic Clearance for Organic Anion Transporting Polypeptide Substrate Drugs Between Different In Vitro-In Vivo Extrapolation Approaches.
    Izumi S; Nozaki Y; Komori T; Takenaka O; Maeda K; Kusuhara H; Sugiyama Y
    J Pharm Sci; 2017 Sep; 106(9):2678-2687. PubMed ID: 28238896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the Protein-Mediated Uptake of Drugs by Organic Anion Transporting Polypeptides a Real Phenomenon or an Artifact?
    Yin M; Storelli F; Unadkat JD
    Drug Metab Dispos; 2022 Sep; 50(9):1132-1141. PubMed ID: 35351775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interpretation of Protein-Mediated Uptake of Statins by Hepatocytes Is Confounded by the Residual Statin-Protein Complex.
    Yin M; Ishida K; Liang X; Lai Y; Unadkat JD
    Drug Metab Dispos; 2023 Oct; 51(10):1381-1390. PubMed ID: 37429727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving Prediction of Metabolic Clearance Using Quantitative Extrapolation of Results Obtained From Human Hepatic Micropatterned Cocultures Model and by Considering the Impact of Albumin Binding.
    Da-Silva F; Boulenc X; Vermet H; Compigne P; Gerbal-Chaloin S; Daujat-Chavanieu M; Klieber S; Poulin P
    J Pharm Sci; 2018 Jul; 107(7):1957-1972. PubMed ID: 29524447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of the overall renal tubular secretion and hepatic clearance of anionic drugs and a renal drug-drug interaction involving organic anion transporter 3 in humans by in vitro uptake experiments.
    Watanabe T; Kusuhara H; Watanabe T; Debori Y; Maeda K; Kondo T; Nakayama H; Horita S; Ogilvie BW; Parkinson A; Hu Z; Sugiyama Y
    Drug Metab Dispos; 2011 Jun; 39(6):1031-8. PubMed ID: 21383204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in preclinical in vitro approaches towards quantitative prediction of hepatic clearance and drug-drug interactions involving organic anion transporting polypeptide (OATP) 1B transporters.
    Nozaki Y; Izumi S
    Drug Metab Pharmacokinet; 2020 Feb; 35(1):56-70. PubMed ID: 31901416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.